Xtandi PREVAILs in Metastatic Castrate-Resistant Prostate Cancer
31 Jan 2014, by Stephanie Hawthorne
Oncology Conference Insight: ASCO GU --- Prostate cancer is the most common cancer in men and the second most common cause of cancer deaths in men in the United States. The incident population of prostate cancer in the United States was above 200,000 patients in 2013. The rate of prostate cancer growth varies from very slow to moderately rapid, and some patients may have prolonged survival even after the cancer has metastasized to distant sites such as bone.
Will an influx of newly insured patients overwhelm healthcare resources?
18 Feb 2014, by Patricia Ensor
One of the most debated aspects of the Affordable Care Act (ACA) is how the newly insured will use existing healthcare resources. Will they overwhelm emergency rooms? Will out-of-pocket costs continue to pose access barriers for these newly insured patients?
Reality or hype? The Egyptian healthcare ‘revolution’ post Arab Spring
17 Oct 2012, by Sherif Shafick
Since the 1960s, Egypt's health profile has grown to be more like developed countries, with longer life expectancy and higher productivity. Yet despite health programs to tackle Poliomyelitis, tuberculosis, viral hepatitis B/C and bilharziasis being offered at no cost to patients, disease rates for cancer, diabetes, heart and chronic respiratory are still high.
Leveraging the Quantified Self Movement for Patient Insights
5 Mar 2014, by Brian Mondry
With the current influx of affordable, non-intrusive wearable technology, the Quantified Self movement is fast approaching its tipping point into the mainstream. Now that a myriad of individual vendors, consumer and pharmaceutical brands have invested heavily in the space, the technology is small and cheap enough to be accessible to the masses. This creates an opportunity to collect and evaluate biometric data on a scale that historically has been impossible.